Hanmi Pharmaceutical Company Limited
Clinical trials sponsored by Hanmi Pharmaceutical Company Limited, explained in plain language.
-
New blood pressure drug HCP1803-4 faces final test
Disease control Not yet recruitingThis phase 3 trial tests whether a new drug called HCP1803-4 can safely lower blood pressure in adults with essential hypertension. Participants are randomly assigned to receive either the new drug or a control drug. The study measures changes in sitting blood pressure over time …
Phase: PHASE3 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Healthy volunteers needed to test how two drug versions behave in the body
Knowledge-focused Not yet recruitingThis early-stage trial will enroll 60 healthy adults to compare two drug formulations: an orally disintegrating tablet (HIP2503) and a standard tablet (HCP1306). The goal is to see how each is absorbed and processed by the body, and to check for safety. Participants will take a s…
Phase: PHASE1 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC